# AstraZeneca is reviving a £200m investment in its Cambridge research facility and spending a further £100m on a project in Macclesfield.

*biotech · news · 2026-04-29 · The Telegraph*

## Key points

- AstraZeneca is reviving its £200m Cambridge research investment and committing £100m to Macclesfield.
- This decision follows a government agreement to pay 25% more for new medicines through the NHS.
- Labour committed to cutting mandatory rebates drug companies pay on sales of newer medicines to the NHS.
- Changes were made partly to avoid US trade tariffs after pharma firms lobbied President Trump on UK pricing.

**Companies:** AstraZeneca
**Countries:** United Kingdom

[Read the full story on The Telegraph](https://www.telegraph.co.uk/business/2026/04/29/astrazeneca-to-invest-300m-in-britain-as-starmer-pays-more/)

---

Canonical: https://newsio.io/n/54a5bafc-8cac-471d-a93a-5ffa584b1923/astrazeneca-is-reviving-a-200m-investment-in-its-cambridge-research-facility-and
Summarized by Newsio from The Telegraph. https://newsio.io/how-it-works